114 related articles for article (PubMed ID: 2881762)
1. Metabolism of the beta-carbolines, harmine and harmol, by liver microsomes from phenobarbitone- or 3-methylcholanthrene-treated mice. Identification and quantitation of two novel harmine metabolites.
Tweedie DJ; Burke MD
Drug Metab Dispos; 1987; 15(1):74-81. PubMed ID: 2881762
[TBL] [Abstract][Full Text] [Related]
2. Effects of induction on the metabolism and cytochrome P-450 binding of harman and other beta-carbolines.
Tweedie DJ; Prough RA; Burke MD
Xenobiotica; 1988 Jul; 18(7):785-96. PubMed ID: 3176517
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of phenobarbitone and 3-methylcholanthrene induction on the hepatic microsomal metabolism of the beta-carbolines harmine and harmol.
Tweedie DJ; Burke MD
Biochem Pharmacol; 1983 Feb; 32(4):653-63. PubMed ID: 6830628
[No Abstract] [Full Text] [Related]
4. Induction by phenobarbitone or 3-methylcholanthrene of the hepatic microsomal metabolism of harmine [proceedings].
Burke MD; Tweedie DJ
Br J Pharmacol; 1979 Jul; 66(3):423P. PubMed ID: 526712
[No Abstract] [Full Text] [Related]
5. Metabolism of antiparkinson agent dopazinol by rat liver microsomes.
Vyas KP; Kari PH; Ramjit HG; Pitzenberger SM; Hichens M
Drug Metab Dispos; 1990; 18(6):1025-30. PubMed ID: 1981508
[TBL] [Abstract][Full Text] [Related]
6. Regioselectivity and stereoselectivity in the metabolism of trans-1,2-dihydroxy-1,2-dihydrobenz[a]anthracene by rat liver microsomes.
Vyas KP; van Bladeren PJ; Thakker DR; Yagi H; Sayer JM; Levin W; Jerina DM
Mol Pharmacol; 1983 Jul; 24(1):115-23. PubMed ID: 6865920
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial dysfunction and biotransformation of β-carboline alkaloids, harmine and harmaline, on isolated rat hepatocytes.
Nakagawa Y; Suzuki T; Ishii H; Ogata A; Nakae D
Chem Biol Interact; 2010 Dec; 188(3):393-403. PubMed ID: 20833158
[TBL] [Abstract][Full Text] [Related]
8. Hepatic and pulmonary microsomal metabolism of naphthalene to glutathione adducts: factors affecting the relative rates of conjugate formation.
Buckpitt AR; Bahnson LS; Franklin RB
J Pharmacol Exp Ther; 1984 Nov; 231(2):291-300. PubMed ID: 6491983
[TBL] [Abstract][Full Text] [Related]
9. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of 6-methylbenz[a]anthracene by rat liver microsomes and mutagenicity of metabolites.
Mushtaq M; Fu PP; Miller DW; Yang SK
Cancer Res; 1985 Sep; 45(9):4006-14. PubMed ID: 3896475
[TBL] [Abstract][Full Text] [Related]
11. Species and phenobarbitone-induced differences in the kinetic constants of liver microsomal harmine O-demethylation.
Burke MD; Upshall DG
Xenobiotica; 1976 May; 6(5):321-8. PubMed ID: 7043
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of 2-acetylaminofluorene by two 3-methylcholanthrene-inducible forms of rat liver cytochrome P-450.
Goldstein JA; Weaver R; Sundheimer DW
Cancer Res; 1984 Sep; 44(9):3768-71. PubMed ID: 6744296
[TBL] [Abstract][Full Text] [Related]
13. In vitro metabolism of the HIV-1 protease inhibitor ABT-378: species comparison and metabolite identification.
Kumar GN; Jayanti V; Lee RD; Whittern DN; Uchic J; Thomas S; Johnson P; Grabowski B; Sham H; Betebenner D; Kempf DJ; Denissen JF
Drug Metab Dispos; 1999 Jan; 27(1):86-91. PubMed ID: 9884314
[TBL] [Abstract][Full Text] [Related]
14. Regioselective and stereoselective metabolisms of pyrene and 1-bromopyrene by rat liver microsomes and effects of enzyme inducers.
Shou M; Yang SK
Drug Metab Dispos; 1988; 16(2):173-83. PubMed ID: 2898329
[TBL] [Abstract][Full Text] [Related]
15. Interspecies metabolic diversity of harmaline and harmine in in vitro 11 mammalian liver microsomes.
Li S; Teng L; Liu W; Cheng X; Jiang B; Wang Z; Wang C
Drug Test Anal; 2017 May; 9(5):754-768. PubMed ID: 27377954
[TBL] [Abstract][Full Text] [Related]
16. The in vitro formation of glutathione conjugates with the microsomally activated pulmonary bronchiolar aklylating agent and cytotoxin, 4-ipomeanol.
Buckpitt AR; Boyd MR
J Pharmacol Exp Ther; 1980 Oct; 215(1):97-103. PubMed ID: 7452496
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and identification of products derived from the metabolism of the carcinostatic 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea by rat liver microsomes.
May HE; Kohlhepp SJ; Boose RB; Reed DJ
Cancer Res; 1979 Mar; 39(3):762-72. PubMed ID: 427763
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of harmol and transport of harmol conjugates in isolated rat hepatocytes.
Sundheimer DW; Brendel K
Drug Metab Dispos; 1983; 11(5):433-40. PubMed ID: 6138228
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of 7,8-dihydrobenzo(a)pyrene by rat liver microsomal enzymes and mutagenicity of metabolites.
Chiu PL; Yang SK
Cancer Res; 1986 Oct; 46(10):5084-94. PubMed ID: 3756866
[TBL] [Abstract][Full Text] [Related]
20. Liquid chromatography/nuclear magnetic resonance spectroscopy and liquid chromatography/mass spectrometry identification of novel metabolites of the multidrug resistance modulator LY335979 in rat bile and human liver microsomal incubations.
Ehlhardt WJ; Woodland JM; Baughman TM; Vandenbranden M; Wrighton SA; Kroin JS; Norman BH; Maple SR
Drug Metab Dispos; 1998 Jan; 26(1):42-51. PubMed ID: 9443851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
